NP89
NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
10/12/2024
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Descrição da marca
The mark consists of the word" LONZA" in block lettering.
Titulares
Representantes
Lawrence J. Crain Greer, Burns & Crain, Ltd.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
chemicals for use in industry and science; [ chemicals for use in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; manures; tempering preparations and soldering chemicals and fluxes; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; ] inorganic and organic salts, namely, carnitine salts and l-carnitine salts; acids, namely, protein and nucleic acids for detection purposes other than for medical and veterinary purposes, docosahexaenoic acids, omega-3 fatty acids and derivatives thereof, [ carboxylic acid, halogenated fatty acids for industrial, manufacturing, or chemical use, and hydroxyacids; saturated and unsaturated aliphatic hydrocarbons; paraffin; aromatic hydrocarbons; organic oxygen compounds, namely, monovalent and multivalent alcoholates, esters, ketones, aldehydes, ethers, anhydrides, and keto compounds; nitrogen compounds, namely, nitrides, nitriles, amines, and amides; cyclic compounds, namely, heterocyclic compounds and compounds containing heteroatoms; carbides; oxides; silicides; borides; phosphates; phosphines; silicates; inorganic compounds containing halogen and sulphur; catalysts for chemical and biochemical processes; aromatic solvents for industrial and commercial use; fire extinguishing and fire retardant compositions; bleaching preparations for industrial purposes; surface active compounds for general use in the industrial arts, namely, emulsifying agents; wetting agents; chemical compound for use as an antimicrobial agent in the manufacture of household, institutional and industrial cleaners, deodorizers, water based paints and stains, and hydraulic fluids; chemical compounds and additives for use in the manufacture of wood preservatives; chemicals for the treatment of wood, namely, chemicals for the prevention of sap stain; chemical compounds for use in the manufacturing of household and industrial disinfectants and sanitizers; ] carnitine and its salts and derivates for use in the production of pharmaceutical preparations, dietetic substances and foodstuffs; chemical preparations and reagents for scientific purposes, namely, isolated human and animal cells cryopreserved and in culture for research purposes; diagnostic reagents for biological and pharmaceutical research and chemical reagents for non-medical purposes, namely, the manufacture of pharmaceutical products; endotoxin detection products, namely, assays and reagents for use in pharmaceutical and biotech research; diagnostic reagents for clinical or medical laboratory use; electrophoresis supplies, namely, nucleic acid stains, DNA markers, and loading buffers for non-medical use, electrophoresis gels other than for medical or veterinary purposes [ ; active chemical ingredients for use in the manufacture of personal care products, namely, hair and skin moisturizing and conditioning agents; chemicals for the treatment of water and wastewater; water treatment chemicals for use in swimming pools and spas ]
Classe 2
[ dyes for textile fabrics; paints; varnishes; lacquers; preservatives against rust in the nature of a coating; anti-corrosive and anti-fouling compositions, namely, paints and coatings; anti-corrosive oils; chemical wood preservatives to prevent decay, deterioration, insect damage and rot; wood preservatives; colorants; raw natural resins; wood stains; enamel paints; distempers; priming preparations and base coats, namely, paints; coating preparations having water repellant properties; waterproof paints; coatings for wood as paints ]
Classe 5
[ antimicrobial preservatives for cosmetics and pharmaceuticals; ] pharmaceutical and veterinary preparations for the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases, lung diseases, neurological diseases, and cancer; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals; medical plasters; bandages for dressings; medical dressings; all purpose disinfectants; [ disinfectants for hygienic and sanitary purposes; multi-purpose disinfectants for household, institutional and industrial use; antimicrobial preservatives for use in the manufacture of cosmetics and toiletries; preparations for destroying vermin; fungicides; herbicides; preparations for killing weeds; insecticides; pesticides; bactericides; germicides; algaecides; preparations for destroying snails and mollusks; ] cell culture media for medical or clinical use and for scientific research, namely, for cultivating human cells, animal cells, and plant cells; antitoxic sera; sera and reagents for biological and pharmaceutical research and for the manufacture of pharmaceutical products; serum-free cell growth media for medical or clinical use; cell culture reagents for medical or clinical use; endotoxin detection assays and reagents for medical or clinical use; deodorizers and sanitizers for industrial and household use; l-carnitine, salts, and derivatives thereof for pharmaceutical use, namely, for the treatment or prevention of cardiovascular diseases, cancer diseases, kidney diseases, diseases and disorders of fat and glucose metabolism, primary and secondary l-carnitine deficiency, male infertility, mental and cognitive diseases, liver diseases, HIV and AIDS, trauma and sepsis, malnutrition, aging and bone loss, or as ingredients of pharmaceutical preparations; l-carnitine, salts and derivatives thereof as dietetic substances adapted for medical use and foodstuffs for medical use; dietary supplements and preparations for treating colds; algaecides, bactericides and virucides for use in recirculating water systems, swimming pools and spas; antiseptics for human and veterinary use
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
10/12/2024
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/12/2024
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
10/12/2024
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
10/12/2024
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/12/2024
TEAS SECTION 8 & 9 RECEIVED
03/09/2024
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
18/11/2023
NOTICE OF SUIT
18/11/2020
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/02/2020
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/02/2020
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/02/2020
TEAS SECTION 8 & 15 RECEIVED
06/12/2019
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
18/11/2019
NOTICE OF SUIT
24/04/2017
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/09/2016
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/09/2016
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
17/06/2015
REGISTERED-PRINCIPAL REGISTER
18/11/2014
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/09/2014
PUBLISHED FOR OPPOSITION
02/09/2014
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/08/2014
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/07/2014
APPROVED FOR PUB - PRINCIPAL REGISTER
29/07/2014
TEAS/EMAIL CORRESPONDENCE ENTERED
24/07/2014
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/07/2014
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/07/2014
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2014
NON-FINAL ACTION E-MAILED
02/07/2014
NON-FINAL ACTION WRITTEN
02/07/2014
TEAS/EMAIL CORRESPONDENCE ENTERED
03/06/2014
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2014
ASSIGNED TO LIE
20/05/2014
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/05/2014
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/03/2014
NON-FINAL ACTION E-MAILED
19/03/2014
NON-FINAL ACTION WRITTEN
19/03/2014
ASSIGNED TO EXAMINER
19/03/2014
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/12/2013
NEW APPLICATION ENTERED
12/12/2013
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.